Gastrografin
Gastrografin-CRE
Unknown small_molecule active
Quick answer
Gastrografin for CRE-induced SBO is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- CRE-induced SBO
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active